Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 1, 2015, Pages 69-74

  Lai, C Y ^a   Yang, T Y ^a,b   Lin, C L ^a,c   Kao, C H ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; CASE CONTROL STUDY; COHORT ANALYSIS; COMPLICATION; FEMALE; HELICOBACTER INFECTION; HUMAN; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK ASSESSMENT; TAIWAN; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HELICOBACTER INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TAIWAN;

EID: 84939872794     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2207-7     Document Type: Article

References (37)

1. Directorate-General of Budget, Accounting and Statistics Executive Yuan, Republic of China (2010) Statistical yearbook of the Republic of China. Health 114
2. Lin YS, Liu PH, Wu LS, Chen YM, Chang CJ, Chu PH (2014) Major adverse cardiovascular events in adult congenital heart disease: a population-based follow-up study from Taiwan. BMC Cardiovasc Disord 14:38
3. Chang KC, Tseng MC (2003) Costs of acute care of first-ever ischemic stroke in Taiwan. Stroke 34:e219–e221
4. Regnström J, Jovinge S, Båvenholm P, Ericsson CG, De Faire U, Hamsten A et al (1998) Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. J Intern Med 243:109–13
5. Ongey M, Brenner H, Thefeld W, Rothenbacher D (2004) Helicobacter pylori and hepatitis a virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population-based study. Eur J Cardiovasc Prev Rehabil 11:471–476
6. Lu YH, Yen HW, Lin TH, Huang CH, Lee KT, Wang WM et al (2002) Changes of coronary risk factors after eradication of Helicobacter pylori infection. Kaohsiung J Med Sci 18:266–272
7. Hara K, Morita Y, Kamihata H, Iwasaka T, Takahashi H (2001) Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction. Clin Chim Acta 313:87–94
8. Mair J, Jaffe AS (2014) Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice? Mol Diagn Ther 18:5–15
9. Wang Y, Wang GZ, Rabinovitch PS, Tabas I (2014) Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages. Circ Res 114:421–433
10. Grufman H, Gonçalves I, Edsfeldt A, Nitulescu M, Persson A, Nilsson M et al (2014) Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques. J Intern Med 275:127–133
11. Khan S, Rahman HN, Okamoto T, Matsunaga T, Fujiwara Y, Sawa T et al (2014) Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci Rep 4:4680
12. Pounder RE, Ng D (1995) The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 9:33–40
13. Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283–97
14. Axon AT (2007) Relationship between Helicobacter pylori gastritis, gastric cancer and gastric acid secretion. Adv Med Sci 52:55–60
15. Kowalski M, Pawlik M, Konturek JW, Konturek SJ (2006) Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol 57:101–111
16. Elizalde JI, Gómez J, Panés J, Lozano M, Casadevall M, Ramírez J et al (1997) Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 100:996–1005
17. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439
18. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M (1996) Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 75:568–572
19. Danesh J, Peto R (1998) Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316:1130–1132
20. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N et al (1995) Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311:711–714
21. Sung KC, Rhee EJ, Ryu SH, Beck SH (2005) Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol 102:411–417
22. Rahman MA, Cope MB, Sarker SA, Garvey WT, Chaudhury HS, Khaled MA (2009) Helicobacter pylori infection and inflammation: implication for the pathophysiology of diabetes and coronary heart disease in Asian Indians. J Life Sci 1:45–50
23. Rogha M, Dadkhah D, Pourmoghaddas Z, Shirneshan K, Nikvarz M, Pourmoghaddas M (2012) Association of helicobacter pylori infection with severity of coronary heart disease. ARYA Atheroscler 7:138–41
24. Hussell T, Isaacson PG, Crabtree JE, Spencer J (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178:122–127
25. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS (2003) Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71:1755–1762
26. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr (2004) Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 189:1914–1920
27. Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL (2007) Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol 51:577–586
28. Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO (2009) Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci 54:1253–1256
29. Eskandarian R, Ghorbani R, Shiyasi M, Momeni B, Hajifathalian K, Madani M (2012) Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study. Cardiovasc J Afr 23:131–135
30. Eskandarian R, Malek M, Mousavi SH, Babaei M (2006) Association of Helicobacter pylori infection with cardiac syndrome X. Singapore Med J 47:704–706
31. Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H et al (2002) Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34:398–402
32. Longo-Mbenza B, Ngoma DV, Nahimana D, Mayuku DM, Fuele SM, Ekwanzala F et al (2008) Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiovasc Prev Rehabil 15:503–508
33. Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR et al (2012) Helicobacter pylori infection is identified as a cardiovascular risk factor in central Africans. Vasc Health Risk Manag 6:455–461
34. D'Ugo E, Rossi S, De Caterina R (2012) Proton pump inhibitors and clopidogrel: an association to avoid? G Ital Cardiol (Rome) 13:817–826
35. Marshall B, Stenström B, Mendis A (2008) Helicobacter pylori: the latest in diagnosis and treatment. Aust Fam Physician 37(8):608
36. Budzyński J, Koziński M, Kłopocka M, Kubica JM, Kubica J (2014) Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. Clin Res Cardiol 1–32
37. Fan C-T, Lin J-C, Lee C-H (2008) Taiwan Biobank: a project aiming to aid Taiwan’s transition into a biomedical island. Pharmacogenomics 9(2):235–246